NDC 81565-202-01 - Dexamethasone Sodium Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81565-202
- Requested NDC
- 81565-202-01
- Package NDCs from labels
- 81565-202-01, 81565-202-02
- Manufacturer
- Phlow Corporation | Fresenius Kabi USA, LLC
- Effective date
- 2024-06-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Sodium Phosphate - Phlow Corporation | Fresenius Kabi USA, LLC | Phlow Corporation | Fresenius Kabi USA, LLC | 2024-06-25 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81565-202-02 | 2024-02-22 | C162847 | 48780-1 | 1030e365-69e4-111a-e063-dadaa90a10e2 | Dexamethasone Sodium Phosphate Injection, USP |
| 81565-202-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-69e4-111a-e063-dadaa90a10e2 | Dexamethasone Sodium Phosphate Injection, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81565-202-01 | Dexamethasone Sodium Phosphate | 1 mL in 1 VIAL | INJECTION, SOLUTION | 1 | 3 | |
| 81565-202-02 | Dexamethasone Sodium Phosphate | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81565-202-01 | ML - Milliliter | 81565-202 | d4cc6f4d-866e-400a-9c10-2cf1604a187e | 1 | 2022-05-04 |
| 81565-202-02 | ML - Milliliter | 81565-202 | b73bdd71-4a09-4d7b-9332-e09f8691f1fb | 1 | 2022-05-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 9f69846e-5897-c301-e053-2a95a90a44f1 | 2023-05-03 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 667323ea-5a5e-3465-e053-2a91aa0a1667 | 2023-04-26 | Warnings, Adverse reactions | AI9376Y64P |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | 2d96d5e8-00bf-406b-b345-f1c31865fe94 | 2023-04-04 | Warnings, Adverse reactions | 1812194 AI9376Y64P |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 94cb045b-5801-db32-e053-2a95a90a93ef | 2022-12-10 | Warnings, Adverse reactions | ANDA084916 AI9376Y64P |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | ca762fbf-6bf5-4b39-8f40-3fb5f1f77778 | 2022-10-12 | Warnings, Adverse reactions | 1812194 AI9376Y64P |
| Bach Original Flower Remedies Rock Water | WATER | Nelson Bach USA Limited | ea242559-1618-3354-e053-2a95a90a1a95 | 2022-10-03 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Bausch & Lomb Incorporated | 6bdcefbe-51e3-4ca4-afda-5aeca7b6fa73 | 2022-08-31 | Warnings, Adverse reactions | AI9376Y64P |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | 1Q73Q2JULR | |
| Sterile Water | WATER | American Regent, Inc. | 78b35864-4bbc-4759-a5c1-7e4f25e22932 | 2022-01-31 | Boxed warning | 059QF0KO0R |
| Sterile Diluent for Treprostinil | WATER | Dr.Reddy's Laboratories Inc., | 33050ee2-519b-1f0b-d4df-9e14dd329c57 | 2021-12-23 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | STERILE WATER | B. Braun Medical Inc. | d99f9133-e4d0-4dee-b611-dbc3f918b547 | 2021-08-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | B. Braun Medical Inc. | 8924e52e-8622-4ed6-a061-1908183e0a18 | 2021-08-06 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.